![](https://cancer.uillinois.edu/wp-content/uploads/2022/03/Gadi-Onclive-3-2-22-Ep11-featured.png)
Special HER2+ mBC Populations: HR+ or HER2-Low Patients
Dr. VK Gadi and expert panelists discuss the optimal management of patients with special subsets of HER2+ metastatic breast cancer, such as HR+ or HER2-low disease.
![](https://cancer.uillinois.edu/wp-content/uploads/2021/08/OncLive_2013_SAP_Seal.jpg)
The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive. View our complete video library.